scPharmaceuticals Inc. Profile Avatar - Palmy Investing

scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through…

Biotechnology
US, Burlington [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

scPharmaceuticals Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

scPharmaceuticals Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of scPharmaceuticals Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SCPH's Analysis
CIK: 1604950 CUSIP: 810648105 ISIN: US8106481059 LEI: - UEI: -
Secondary Listings
SCPH has no secondary listings inside our databases.